Exact Mass: 352.21238700000004
Exact Mass Matches: 352.21238700000004
Found 80 metabolites which its exact mass value is equals to given mass value 352.21238700000004,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tebufenozide
CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4696; ORIGINAL_PRECURSOR_SCAN_NO 4694 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4687; ORIGINAL_PRECURSOR_SCAN_NO 4683 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9485; ORIGINAL_PRECURSOR_SCAN_NO 9481 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4702; ORIGINAL_PRECURSOR_SCAN_NO 4700 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4698; ORIGINAL_PRECURSOR_SCAN_NO 4696 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9523; ORIGINAL_PRECURSOR_SCAN_NO 9521 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9469; ORIGINAL_PRECURSOR_SCAN_NO 9467 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4672; ORIGINAL_PRECURSOR_SCAN_NO 4668 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9480; ORIGINAL_PRECURSOR_SCAN_NO 9479 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4704; ORIGINAL_PRECURSOR_SCAN_NO 4703 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9513; ORIGINAL_PRECURSOR_SCAN_NO 9510 CONFIDENCE standard compound; INTERNAL_ID 1270; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9506; ORIGINAL_PRECURSOR_SCAN_NO 9503 D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
Encainide
All drug products containing encainide hydrochloride. Encainide hydrochloride, formerly marketed as Enkaid capsules, was associated with increased death rates in patients who had asymptomatic heart rhythm abnormalities after a recent heart attack. The manufacturer of Enkaid capsules voluntarily withdrew the product from the US market on December 16, 1991. C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BC - Antiarrhythmics, class ic D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Anileridine
Anileridine is a synthetic opioid and strong analgesic medication. It is a narcotic pain reliever used to treat moderate to severe pain. Narcotic analgesics act in the central nervous system (CNS) to relieve pain. Some of their side effects are also caused by actions in the CNS. N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AH - Opioid anesthetics C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
Methyl (9Z)-8'-oxo-6,8'-diapo-6-carotenoate
Methyl (9Z)-8-oxo-6,8-diapo-6-carotenoate is a constituent of Bixa orellana (annatto) Constituent of Bixa orellana (annatto).
2-(4-Hydroxy-3,5-di-tert-butylphenylthio)-hexanoic acid
Posatirelin
11,17-Dihydroxy-6-methyl-17-(1-propynyl)androsta-1,4,6-triene-3-one
2-Methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
methyl 6-deoxy-1,3-di-O-methyl-beta-D-ribo-hexosyl-(1->4)-2,6-dideoxy-3-O-methyl-alpha-D-arabino-hexopyranoside
(8E,16S)-16-Hydroxy-8-tricosene-4,6,17,19-tetraynoic acid
all-E-citreomontanin|Citreomontanin|citreomontanine
Tebufenozide
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; EAWAG_UCHEM_ID 2952 EAWAG_UCHEM_ID 2952; CONFIDENCE standard compound
ANILERIDINE
N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AH - Opioid anesthetics C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
1-ethyl-4-[2-(2-hydroxyethylamino)ethyl]-3,3-diphenylpyrrolidin-2-one
Apo-8'-bixinal
1-PYRROLIDIN-3-PHENYL-3-(N-CBZ-N-METHYL)AMINO-ETHANE
Posatirelin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C76367 - Thyrotropin-Releasing Hormone Analogue D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
tert-butyl 1-benzhydrylazetidin-3-yl(Methyl)carbamate
N-[1-[2-(4-hydroxyphenyl)ethyl]piperidin-4-yl]-N-phenylpropanamide
N-[1-(1-hydroxy-2-phenylethyl)piperidin-4-yl]-N-phenylpropanamide
N-(4-methoxyphenyl)-N-[2-(6-methylpyridin-2-yl)ethyl]cyclohexanecarboxamide
11,17-dihydroxy-6,10,13-trimethyl-17-prop-1-ynyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one
10-(3-Carboxypropyl)-3,6-bis(dimethylamino)acridinium
C21H26N3O2+ (352.20249160000003)
N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-(4-phenylphenyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide
N-[[(2S,3S,4S)-4-(hydroxymethyl)-3-(4-phenylphenyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide
N-[[(2R,3R,4R)-4-(hydroxymethyl)-3-(4-phenylphenyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide
N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-(4-phenylphenyl)-2-azetidinyl]methyl]-N-propan-2-ylacetamide
Methyl (9R,18R,21S)-2-methyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate
methyl (1R,16R,18R,21S)-2-methyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate
(9R,17S)-9-fluoro-6,11,17-trihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
Encainide
C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BC - Antiarrhythmics, class ic D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker